MorphoSys Gets $1.4M to Develop Cancer Program, Explore Biomarkers

As part of the effort, MorphoSys will explore relevant biomarkers for the anti-CD38 approach in collaboration with the university hospital of Munich Technical University.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories